ConvaTec

Sector/industry

Ostomy, wound care and hospital products

ConvaTec is a leading developer and marketer of innovative medical technologies. With four key business divisions, ostomy care, wound therapeutics, continence and critical care and infusion devices, ConvaTec products support health care professionals from the hospital to the community health setting. The company has operations in over 90 countries serving consumers and health care professionals on six continents.

Nordic Capital Funds VI and VII, together with Avista Capital partners acquired Convatec from Bristol Myers Squibb in August 2008.

After the acquisition by Nordic Capital, ConvaTec has integrated Unomedical, a leading manufacturer of single-use medical devices based in Copenhagen and a Nordic Capital portfolio company since 2003.

Management:
  • Ken Berger, CEO
  • John Cannon, CFO
Key Information: Revenues 2013*: EUR 1260 million Employees: 8570 Ownership: Nordic Capital Fund VI and Fund VII, controlling shareholding Date of investment: 2008
* Normalized pro-forma adjusted for FX effects